Skip to main content
Top
Published in: European Radiology 8/2022

Open Access 21-03-2022 | Acute Kidney Injury | Contrast Media

A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2—intra-arterial administration

Authors: Aart J. van der Molen, Ilona A. Dekkers, Ibrahim Bedioune, Elisabeth Darmon-Kern

Published in: European Radiology | Issue 8/2022

Login to get access

Abstract

Objectives

To evaluate the incidence of adverse drug reactions (ADRs), including hypersensitivity reactions (HSRs) and post-contrast acute kidney injury (PC-AKI), after intra-arterial (IA) administration of ioversol.

Methods and materials

A systematic literature search was performed (1980–2021) and studies documenting IA use of ioversol, and reporting safety outcomes were selected. Key information on study design, patients’ characteristics, indication, dose, and type of safety outcome were extracted.

Results

Twenty-eight studies (including two pediatric studies) with 8373 patients exposed to IA ioversol were selected. Studies were highly heterogenous in terms of design, PC-AKI definition, and studied population. PC-AKI incidence after coronary angiography was 7.5–21.9% in a general population, 4.0-26.4% in diabetic patients, and 5.5–28.9% in patients with chronic kidney disease (CKD). PC-AKI requiring dialysis was rare and reported mainly in patients with severe CKD. No significant differences in PC-AKI rates were shown in studies comparing different iodinated contrast media (ICM). Based on seven studies of ioversol clinical development, the overall ADR incidence was 1.6%, comparable to that reported with other non-ionic ICM. Pediatric data were scarce with only one study reporting on PC-AKI incidence (12%), and one reporting on ADR incidence (0.09%), both after coronary angiography.

Conclusions

After ioversol IA administration, PC-AKI incidence was highly variable between studies, likely reflecting the heterogeneity of the included study populations, and appeared comparable to that reported with other ICM. The rate of other ADRs appears to be low. Well-designed studies are needed for a better comparison with other ICM.

Key Points

• PC-AKI incidence after IA administration of ioversol appears to be comparable to that of other ICM, despite the high variability between studies.
• The need for dialysis after IA administration of ioversol is rare.
• No obvious difference was found regarding the safety profile of ioversol between IA and IV administration.
Literature
1.
go back to reference Demoly P, Adkinson NF, Brockow K et al (2014) International consensus on drug allergy. Allergy 69:420–437PubMedCrossRef Demoly P, Adkinson NF, Brockow K et al (2014) International consensus on drug allergy. Allergy 69:420–437PubMedCrossRef
2.
go back to reference Kooiman J, Pasha SM, Zondag W et al (2012) Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 81:2554–2561PubMedCrossRef Kooiman J, Pasha SM, Zondag W et al (2012) Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 81:2554–2561PubMedCrossRef
3.
go back to reference Rao QA, Newhouse JH (2006) Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 239:392–397PubMedCrossRef Rao QA, Newhouse JH (2006) Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 239:392–397PubMedCrossRef
4.
go back to reference From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS (2008) Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 83:1095–1100PubMedCrossRef From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS (2008) Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 83:1095–1100PubMedCrossRef
5.
go back to reference Azzalini L, Kalra S (2020) Contrast-induced acute kidney injury-definitions, epidemiology, and implications. Interv Cardiol Clin 9:299–309PubMed Azzalini L, Kalra S (2020) Contrast-induced acute kidney injury-definitions, epidemiology, and implications. Interv Cardiol Clin 9:299–309PubMed
6.
go back to reference Endrikat J, Michel A, Kölbach R, Lengsfeld P, Vogtländer K (2020) Risk of hypersensitivity reactions to iopromide after intra-arterial versus intravenous administration: a nested case-control analysis of 133,331 patients. Invest Radiol 55:38–44 Endrikat J, Michel A, Kölbach R, Lengsfeld P, Vogtländer K (2020) Risk of hypersensitivity reactions to iopromide after intra-arterial versus intravenous administration: a nested case-control analysis of 133,331 patients. Invest Radiol 55:38–44
7.
go back to reference Meurer K, Laniado M, Hosten N, Kelsch B, Hogstrom B (2015) Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience. Acta Radiol 56:702–708PubMedPubMedCentralCrossRef Meurer K, Laniado M, Hosten N, Kelsch B, Hogstrom B (2015) Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience. Acta Radiol 56:702–708PubMedPubMedCentralCrossRef
8.
go back to reference van der Molen AJ, Reimer P, Dekkers IA et al (2018) Post-contrast acute kidney injury - part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 28:2845–2855PubMedPubMedCentralCrossRef van der Molen AJ, Reimer P, Dekkers IA et al (2018) Post-contrast acute kidney injury - part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 28:2845–2855PubMedPubMedCentralCrossRef
11.
go back to reference van der Molen AJ, Dekkers IA, Bedioune I, Darmon-Kern E (2021) A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1 - intravenous administration. Eur Radiol EURA-D-21-02907 van der Molen AJ, Dekkers IA, Bedioune I, Darmon-Kern E (2021) A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1 - intravenous administration. Eur Radiol EURA-D-21-02907
12.
go back to reference Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1PubMedPubMedCentralCrossRef Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1PubMedPubMedCentralCrossRef
14.
go back to reference Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898PubMedCrossRef Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898PubMedCrossRef
15.
go back to reference Abaci O, Arat Ozkan A, Kocas C et al (2015) Impact of rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. Am J Cardiol 115:867–871PubMedCrossRef Abaci O, Arat Ozkan A, Kocas C et al (2015) Impact of rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. Am J Cardiol 115:867–871PubMedCrossRef
16.
go back to reference Azzalini L, Vilca LM, Lombardo F et al (2018) Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: comparison of five contrast media. Int J Cardiol 273:69–73PubMedCrossRef Azzalini L, Vilca LM, Lombardo F et al (2018) Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: comparison of five contrast media. Int J Cardiol 273:69–73PubMedCrossRef
17.
go back to reference Azzalini L, Laricchia A, Regazzoli D et al (2019) Ultra-low contrast percutaneous coronary intervention to minimize the risk for contrast-induced acute kidney injury in patients with severe chronic kidney disease. J Invasive Cardiol 31:176–182PubMed Azzalini L, Laricchia A, Regazzoli D et al (2019) Ultra-low contrast percutaneous coronary intervention to minimize the risk for contrast-induced acute kidney injury in patients with severe chronic kidney disease. J Invasive Cardiol 31:176–182PubMed
18.
go back to reference Baskurt M, Okcun B, Abaci O et al (2009) N-Acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy. Eur J Clin Invest 39:793–799 Baskurt M, Okcun B, Abaci O et al (2009) N-Acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy. Eur J Clin Invest 39:793–799
19.
go back to reference Call J, Sacrinty M, Applegate R et al (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol 18:469–474PubMed Call J, Sacrinty M, Applegate R et al (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol 18:469–474PubMed
20.
go back to reference Cho R, Javed N, Traub D, Kodali S, Atem F, Srinivasan V (2010) Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. J Interv Cardiol 23:460–466PubMedCrossRef Cho R, Javed N, Traub D, Kodali S, Atem F, Srinivasan V (2010) Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. J Interv Cardiol 23:460–466PubMedCrossRef
21.
go back to reference Cury MVM, Matielo MF, Brochado Neto FC et al (2018) The incidence, risk factors, and outcomes of contrast-induced nephropathy in patients with critical limb ischemia following lower limb angiography. Angiology 69:700–708PubMedCrossRef Cury MVM, Matielo MF, Brochado Neto FC et al (2018) The incidence, risk factors, and outcomes of contrast-induced nephropathy in patients with critical limb ischemia following lower limb angiography. Angiology 69:700–708PubMedCrossRef
22.
go back to reference El-saadani R, Ibrahim O, El-Haggar S, Khalel S (2017) Outcomes of different pre-procedural loading doses of atorvastatin in patients undergoing elective percutaneous coronary intervention. Int J Pharm Sci Rev Res 45:153–160 El-saadani R, Ibrahim O, El-Haggar S, Khalel S (2017) Outcomes of different pre-procedural loading doses of atorvastatin in patients undergoing elective percutaneous coronary intervention. Int J Pharm Sci Rev Res 45:153–160
23.
go back to reference Hernández F, Mora L, García-Tejada J et al (2009) Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. Rev Esp Cardiol 62:1373–1380PubMedCrossRef Hernández F, Mora L, García-Tejada J et al (2009) Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. Rev Esp Cardiol 62:1373–1380PubMedCrossRef
24.
go back to reference Hirsch R, Dent C, Pfriem H et al (2007) NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089–2095PubMedCrossRef Hirsch R, Dent C, Pfriem H et al (2007) NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089–2095PubMedCrossRef
25.
go back to reference Komenda P, Zalunardo N, Burnett S et al (2007) Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series. Clin Exp Nephrol 11:209–213PubMedCrossRef Komenda P, Zalunardo N, Burnett S et al (2007) Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series. Clin Exp Nephrol 11:209–213PubMedCrossRef
26.
go back to reference Krol AL, Dzialowski I, Roy J et al (2007) Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke 38:2364–2366PubMedCrossRef Krol AL, Dzialowski I, Roy J et al (2007) Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke 38:2364–2366PubMedCrossRef
27.
go back to reference Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF, VALOR Trial Investigators (2008) Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J 156:776–782 Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF, VALOR Trial Investigators (2008) Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J 156:776–782
28.
go back to reference Senthilnathan S, Gauvreau K, Marshall AC, Lock JE, Bergersen L (2009) Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv 73:814–820PubMedPubMedCentralCrossRef Senthilnathan S, Gauvreau K, Marshall AC, Lock JE, Bergersen L (2009) Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv 73:814–820PubMedPubMedCentralCrossRef
29.
go back to reference Sharma J, Nanda A, Jung RS, Mehta S, Pooria J, Hsu DP (2013) Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke. J Neurointerv Surg 5:543–545PubMedCrossRef Sharma J, Nanda A, Jung RS, Mehta S, Pooria J, Hsu DP (2013) Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke. J Neurointerv Surg 5:543–545PubMedCrossRef
30.
go back to reference Sohn K-H, Kim G-W, Lee S-Y et al (2019) Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography. Eur Radiol 29:5314–5321PubMedCrossRef Sohn K-H, Kim G-W, Lee S-Y et al (2019) Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography. Eur Radiol 29:5314–5321PubMedCrossRef
31.
go back to reference Wróbel W, Sinkiewicz W, Gordon M, Woźniak-Wiśniewska A (2010) Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Kardiol Pol 68:1015–1020PubMed Wróbel W, Sinkiewicz W, Gordon M, Woźniak-Wiśniewska A (2010) Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Kardiol Pol 68:1015–1020PubMed
32.
go back to reference Zaki T, Samir A, Mohammed Rashid T, Galal H, Samir W (2015) Assessment of estimated GFR and clinical predictors of contrast induced nephropathy among diabetic patients undergoing cardiac catheterization. Egypt Heart J 67:249–258CrossRef Zaki T, Samir A, Mohammed Rashid T, Galal H, Samir W (2015) Assessment of estimated GFR and clinical predictors of contrast induced nephropathy among diabetic patients undergoing cardiac catheterization. Egypt Heart J 67:249–258CrossRef
33.
go back to reference Cutcliff WB, Schwarten DE (1989) A double-blind comparative study of the safety, tolerability, and efficacy of ioversol and iohexol in peripheral and visceral arteriography. Invest Radiol 24(Suppl 1):S56–S59 Cutcliff WB, Schwarten DE (1989) A double-blind comparative study of the safety, tolerability, and efficacy of ioversol and iohexol in peripheral and visceral arteriography. Invest Radiol 24(Suppl 1):S56–S59
34.
go back to reference Grassi CJ, Bettmann MA, Finkelstein J, Reagan K (1989) Ioversol. Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography. Invest Radiol 24:133–137 Grassi CJ, Bettmann MA, Finkelstein J, Reagan K (1989) Ioversol. Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography. Invest Radiol 24:133–137
35.
go back to reference Hirshfeld JW, Wieland J, Davis CA et al (1989) Hemodynamic and electrocardiographic effects of ioversol during cardiac angiography. Comparison with iopamidol and diatrizoate. Invest Radiol 24:138–144 Hirshfeld JW, Wieland J, Davis CA et al (1989) Hemodynamic and electrocardiographic effects of ioversol during cardiac angiography. Comparison with iopamidol and diatrizoate. Invest Radiol 24:138–144
36.
go back to reference McGaughey MD, Remetz MS, Sharf-Bornhofen E (1991) A double-blind study comparing the safety, tolerability, and efficacy of ioversol-350 and iohexol-350 in coronary arteriography with left ventriculography. J Invasive Cardiol 3:272–277 McGaughey MD, Remetz MS, Sharf-Bornhofen E (1991) A double-blind study comparing the safety, tolerability, and efficacy of ioversol-350 and iohexol-350 in coronary arteriography with left ventriculography. J Invasive Cardiol 3:272–277
37.
go back to reference Miller FJ, Pollei SR, Osborn AG (1989) Efficacy, safety, and tolerability of ioversol in intra-arterial digital subtraction angiography. Invest Radiol 24(Suppl 1):S52–S54 Miller FJ, Pollei SR, Osborn AG (1989) Efficacy, safety, and tolerability of ioversol in intra-arterial digital subtraction angiography. Invest Radiol 24(Suppl 1):S52–S54
38.
go back to reference Ringel K, Kuehn J (1989) A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol-300 in cerebral angiography. Invest Radiol 24(Suppl 1):S48–S51 Ringel K, Kuehn J (1989) A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol-300 in cerebral angiography. Invest Radiol 24(Suppl 1):S48–S51
39.
go back to reference Reagan K, Bettman MA, Finkelstein J, Ganz P, Grassi CJ (1988) Double-blind study of a new nonionic contrast agent for cardiac angiography. Radiology 167:409–413PubMedCrossRef Reagan K, Bettman MA, Finkelstein J, Ganz P, Grassi CJ (1988) Double-blind study of a new nonionic contrast agent for cardiac angiography. Radiology 167:409–413PubMedCrossRef
40.
go back to reference Cao B, Zhang C, Wang H, Xia M, Yang X (2018) Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Ther Clin Risk Manag 14:369–375PubMedPubMedCentralCrossRef Cao B, Zhang C, Wang H, Xia M, Yang X (2018) Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Ther Clin Risk Manag 14:369–375PubMedPubMedCentralCrossRef
41.
go back to reference Xu Q, Wang NN, Duan SB et al (2017) Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography. J Clin Lab Anal:31 Xu Q, Wang NN, Duan SB et al (2017) Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography. J Clin Lab Anal:31
42.
go back to reference Fu N, Yang S, Zhang J et al (2018) The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study. Int Urol Nephrol 50:105–112PubMedCrossRef Fu N, Yang S, Zhang J et al (2018) The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study. Int Urol Nephrol 50:105–112PubMedCrossRef
43.
go back to reference LaBounty TM, Shah M, Raman SV, Lin FY, Berman DS, Min JK (2012) Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. Am J Cardiol 109:1594–1599PubMedCrossRef LaBounty TM, Shah M, Raman SV, Lin FY, Berman DS, Min JK (2012) Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. Am J Cardiol 109:1594–1599PubMedCrossRef
44.
go back to reference Schönenberger E, Martus P, Bosserdt M et al (2019) Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial. Radiology 292:664–672PubMedCrossRef Schönenberger E, Martus P, Bosserdt M et al (2019) Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial. Radiology 292:664–672PubMedCrossRef
45.
go back to reference Kooiman J, Le Haen PA, Gezgin G et al (2013) Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J 165:793–799.e791PubMedCrossRef Kooiman J, Le Haen PA, Gezgin G et al (2013) Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J 165:793–799.e791PubMedCrossRef
46.
go back to reference McDonald JS, Leake CB, McDonald RJ et al (2016) Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort. Invest Radiol 51:804–809 McDonald JS, Leake CB, McDonald RJ et al (2016) Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort. Invest Radiol 51:804–809
47.
go back to reference Tong GE, Kumar S, Chong KC et al (2016) Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration. Abdom Radiol (NY) 41:91–99 Tong GE, Kumar S, Chong KC et al (2016) Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration. Abdom Radiol (NY) 41:91–99
48.
go back to reference Karlsberg RP, Dohad SY, Sheng R, Iodixanol peripheral computed tomographic angiography study investigator panel (2011) Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol 22:1159–1165 Karlsberg RP, Dohad SY, Sheng R, Iodixanol peripheral computed tomographic angiography study investigator panel (2011) Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol 22:1159–1165
49.
go back to reference Chaudhury P, Armanyous S, Harb SC et al (2019) Intra-arterial versus intravenous contrast and renal injury in chronic kidney disease: a propensity-matched analysis. Nephron 141:31–40PubMedCrossRef Chaudhury P, Armanyous S, Harb SC et al (2019) Intra-arterial versus intravenous contrast and renal injury in chronic kidney disease: a propensity-matched analysis. Nephron 141:31–40PubMedCrossRef
50.
go back to reference Davenport MS, Perazella MA, Yee J et al (2020) Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 2:85–93PubMedPubMedCentralCrossRef Davenport MS, Perazella MA, Yee J et al (2020) Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 2:85–93PubMedPubMedCentralCrossRef
51.
go back to reference Takahashi EA, Kallmes DF, Fleming CJ et al (2017) Predictors and outcomes of postcontrast acute kidney injury after endovascular renal artery intervention. J Vasc Interv Radiol 28:1687–1692PubMedPubMedCentralCrossRef Takahashi EA, Kallmes DF, Fleming CJ et al (2017) Predictors and outcomes of postcontrast acute kidney injury after endovascular renal artery intervention. J Vasc Interv Radiol 28:1687–1692PubMedPubMedCentralCrossRef
52.
go back to reference Shoukat S, Gowani SA, Jafferani A, Dhakam SH (2010) Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract 2010 Shoukat S, Gowani SA, Jafferani A, Dhakam SH (2010) Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract 2010
53.
go back to reference Liu L, Liang Y, Li H et al (2021) Association between diabetes mellitus and contrast-associated acute kidney injury: a systematic review and meta-analysis of 1.1 million contrast exposure patients. Nephron 145: 451-461 Liu L, Liang Y, Li H et al (2021) Association between diabetes mellitus and contrast-associated acute kidney injury: a systematic review and meta-analysis of 1.1 million contrast exposure patients. Nephron 145: 451-461
55.
go back to reference Kim J, Male S, Jagadeesan BD, Streib C, Tummala RP (2018) Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease. Neuroradiology 60:529–533PubMedCrossRef Kim J, Male S, Jagadeesan BD, Streib C, Tummala RP (2018) Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease. Neuroradiology 60:529–533PubMedCrossRef
56.
go back to reference Myung JW, Kim JH, Cho J, Park I, Kim HY, Beom JH (2020) Contrast-induced acute kidney injury in radiologic management of acute ischemic stroke in the emergency setting. AJNR Am J Neuroradiol 41:632–636 Myung JW, Kim JH, Cho J, Park I, Kim HY, Beom JH (2020) Contrast-induced acute kidney injury in radiologic management of acute ischemic stroke in the emergency setting. AJNR Am J Neuroradiol 41:632–636
57.
go back to reference Weber R, van Hal R, Stracke P, Hadisurya J, Nordmeyer H, Chapot R (2020) Incidence of acute kidney injury after computed tomography angiography±computed tomography perfusion followed by thrombectomy in patients with stroke using a postprocedural hydration protocol. J Am Heart Assoc 9:e014418PubMedPubMedCentralCrossRef Weber R, van Hal R, Stracke P, Hadisurya J, Nordmeyer H, Chapot R (2020) Incidence of acute kidney injury after computed tomography angiography±computed tomography perfusion followed by thrombectomy in patients with stroke using a postprocedural hydration protocol. J Am Heart Assoc 9:e014418PubMedPubMedCentralCrossRef
58.
go back to reference Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM (2016) Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv 88:264–273PubMedCrossRef Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM (2016) Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv 88:264–273PubMedCrossRef
59.
go back to reference Gruberg L, Mehran R, Dangas G et al (2001) Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52:409–416PubMedCrossRef Gruberg L, Mehran R, Dangas G et al (2001) Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52:409–416PubMedCrossRef
60.
go back to reference Tsai T-M, Chiang X-H, Liao H-C et al (2019) Computed tomography-guided dye localization for deeply situated pulmonary nodules in thoracoscopic surgery. Ann Transl Med 7: 31 Tsai T-M, Chiang X-H, Liao H-C et al (2019) Computed tomography-guided dye localization for deeply situated pulmonary nodules in thoracoscopic surgery. Ann Transl Med 7: 31
61.
go back to reference Inohara T, Kohsaka S, Miyata H et al (2016) Performance and validation of the U.S. NCDR acute kidney injury prediction model in Japan. J Am Coll Cardiol 67:1715–1722PubMedCrossRef Inohara T, Kohsaka S, Miyata H et al (2016) Performance and validation of the U.S. NCDR acute kidney injury prediction model in Japan. J Am Coll Cardiol 67:1715–1722PubMedCrossRef
62.
go back to reference Heinrich MC, Häberle L, Müller V, Bautz W, Uder M (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250:68–86PubMedCrossRef Heinrich MC, Häberle L, Müller V, Bautz W, Uder M (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250:68–86PubMedCrossRef
63.
go back to reference McCullough PA, Brown JR (2011) Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: a meta-analysis. Cardiorenal Med 1:220–234PubMedPubMedCentralCrossRef McCullough PA, Brown JR (2011) Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: a meta-analysis. Cardiorenal Med 1:220–234PubMedPubMedCentralCrossRef
64.
go back to reference Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA (2009) Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital--retrospective analysis of data in 12,494 patients. Radiology 250:674–681PubMedCrossRef Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA (2009) Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital--retrospective analysis of data in 12,494 patients. Radiology 250:674–681PubMedCrossRef
Metadata
Title
A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2—intra-arterial administration
Authors
Aart J. van der Molen
Ilona A. Dekkers
Ibrahim Bedioune
Elisabeth Darmon-Kern
Publication date
21-03-2022
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2022
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08637-2

Other articles of this Issue 8/2022

European Radiology 8/2022 Go to the issue